Bialecki RA - Search Results

1

Functional comparison of endothelin receptors in human and rat pulmonary artery smooth muscle.

Bialecki RA, Fisher CS, Murdoch WW, Barthlow HG, Bertelsen DL. Bialecki RA, et al. Am J Physiol. 1997 Feb;272(2 Pt 1):L211-8. doi: 10.1152/ajplung.1997.272.2.L211. Am J Physiol. 1997. PMID: 9124371

2

Hypoxic exposure time dependently modulates endothelin-induced contraction of pulmonary artery smooth muscle.

Bialecki RA, Fisher CS, Murdoch WW, Barthlow HG, Stow RB, Mallamaci M, Rumsey W. Bialecki RA, et al. Am J Physiol. 1998 Apr;274(4):L552-9. doi: 10.1152/ajplung.1998.274.4.L552. Am J Physiol. 1998. PMID: 9575873

3

A novel orally active endothelin-A receptor antagonist, ZD1611, prevents chronic hypoxia-induced pulmonary hypertension in the rat.

Bialecki RA, Stinson-Fisher C, Murdoch W, Bertelsen D, Desiato M, Rumsey W. Bialecki RA, et al. Chest. 1998 Jul;114(1 Suppl):91S. doi: 10.1378/chest.114.1_supplement.91s. Chest. 1998. PMID: 9676649 No abstract available.

4

Chronic hypoxia increases staurosporine sensitivity of pulmonary artery smooth muscle to endothelin-1.

Bialecki RA, Fisher CS, Murdoch WW, Barthlow HG. Bialecki RA, et al. Pulm Pharmacol Ther. 1998 Apr-Jun;11(2-3):159-63. doi: 10.1006/pupt.1998.0131. Pulm Pharmacol Ther. 1998. PMID: 9918749

5

ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.

Bialecki RA, Fisher CS, Abbott BM, Barthlow HG, Caccese RG, Stow RB, Rumsey J, Rumsey W. Bialecki RA, et al. Pulm Pharmacol Ther. 1999;12(5):303-12. doi: 10.1006/pupt.1999.0211. Pulm Pharmacol Ther. 1999. PMID: 10545286

6

Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.

Rumsey WL, Aharony D, Bialecki RA, Abbott BM, Barthlow HG, Caccese R, Ghanekar S, Lengel D, McCarthy M, Wenrich B, Undem B, Ohnmacht C, Shenvi A, Albert JS, Brown F, Bernstein PR, Russell K. Rumsey WL, et al. Among authors: bialecki ra. J Pharmacol Exp Ther. 2001 Jul;298(1):307-15. J Pharmacol Exp Ther. 2001. PMID: 11408556

7

Discovery of novel, orally active dual NK1/NK2 antagonists.

Bernstein PR, Aharony D, Albert JS, Andisik D, Barthlow HG, Bialecki R, Davenport T, Dedinas RF, Dembofsky BT, Koether G, Kosmider BJ, Kirkland K, Ohnmacht CJ, Potts W, Rumsey WL, Shen L, Shenvi A, Sherwood S, Stollman D, Russell K. Bernstein PR, et al. Bioorg Med Chem Lett. 2001 Oct 22;11(20):2769-73. doi: 10.1016/s0960-894x(01)00572-8. Bioorg Med Chem Lett. 2001. PMID: 11591520

8

Design, synthesis, and SAR of tachykinin antagonists: modulation of balance in NK(1)/NK(2) receptor antagonist activity.

Albert JS, Aharony D, Andisik D, Barthlow H, Bernstein PR, Bialecki RA, Dedinas R, Dembofsky BT, Hill D, Kirkland K, Koether GM, Kosmider BJ, Ohnmacht C, Palmer W, Potts W, Rumsey W, Shen L, Shenvi A, Sherwood S, Warwick PJ, Russell K. Albert JS, et al. Among authors: bialecki ra. J Med Chem. 2002 Aug 29;45(18):3972-83. doi: 10.1021/jm020094i. J Med Chem. 2002. PMID: 12190319

9

Effects of M274773, a neurokinin-2 receptor antagonist, on bladder function in chronically spinalized rats.

Abdel-Karim AM, Barthlow HG, Bialecki RA, Elhilali MM. Abdel-Karim AM, et al. Among authors: bialecki ra. J Urol. 2005 Oct;174(4 Pt 1):1488-92. doi: 10.1097/01.ju.0000173004.61302.75. J Urol. 2005. PMID: 16145477

10

KCa channel antagonists reduce NO donor-mediated relaxation of vascular and tracheal smooth muscle.

Bialecki RA, Stinson-Fisher C. Bialecki RA, et al. Am J Physiol. 1995 Jan;268(1 Pt 1):L152-9. doi: 10.1152/ajplung.1995.268.1.L152. Am J Physiol. 1995. PMID: 7840222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters